Companion Diagnostics News on companion diagnostics and drug/test co-development. FDA Approves Bile Duct Cancer Drug from Helsinn, BridgeBio Pharma With Foundation Medicine CDx Truseltiq is a new option for FGFR2 fusion-positive, locally advanced, or metastatic cholangiocarcinoma patients who have received prior treatment. FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC. Qiagen, Mirati Therapeutics Partner to Develop KRAS Companion Test for NSCLC Drug The tissue-based test will identify cancer patients who may benefit from adagrasib, Mirati's investigational oral small molecule inhibitor of KRAS G12C. LGC SeraCare Joins Diaceutics DXRX Network for Precision Medicine Diagnostics The partnership will introduce additional types of test reference materials to users of the platform, including the Seraseq FFPE Tumor Fusion RNA Reference Material v4. Burning Rock Biotech, Abbisko Therapeutics Ink CDx Partnership for ABSK091 Burning Rock will use its sequencing platform to identify urothelial carcinoma patients with FGFR alterations, supporting development of Abbisko's drug. Apr 22, 2021 Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic Apr 6, 2021 Roche to Use Oncimmune Infectious Disease Panel in COVID-19 Drug Trial Mar 30, 2021 MapKure, Personalis Partner to Screen Patients for BRAF Inhibitor Trial Mar 12, 2021 Prometheus Biosciences Prices Upsized $190M IPO Mar 2, 2021 Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service Feb 24, 2021 Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy Feb 19, 2021 AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance Jan 13, 2021 Tempus, A2 Biotherapeutics Partner to Develop CDx for Therapy Targeting Loss of Heterozygosity Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 5, 2021 Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence Dec 11, 2020 BTIG Initiates Coverage of NeoGenomics With Buy Rating Dec 2, 2020 Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium Nov 23, 2020 FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic Nov 18, 2020 Qiagen to Develop Companion Diagnostic for BioNTech Head, Neck Cancer Treatment Nov 16, 2020 Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China Nov 13, 2020 FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer Nov 9, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza Nov 3, 2020 Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Nov 2, 2020 LabCorp Expands Companion Dx Agreement With BML Oct 29, 2020 Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.